[Ip-health] Press links on OTA and lack of Bayh-Dole safeguards in COVID-contracts

Claire Cassedy claire.cassedy at keionline.org
Thu Jul 2 08:31:35 PDT 2020


Below are links to some of the press coverage on the Other Transaction
Authority agreement issue and the COVID-related OTAs.

Christopher Rowland. "Trump administration makes it easier for drugmakers
to profit from publicly funded coronavirus drugs, advocates say."
Washington Post. July 1, 2020.
https://www.washingtonpost.com/business/2020/07/01/vaccine-coronavirus-barda-trump/

Bob Herman. “Federal government weakened its march-in rights for
coronavirus drugs.” Axios. July 1, 2020.
https://www.axios.com/federal-government-barda-contracts-moderna-regeneron-aaf9fde2-2ee1-46fb-8465-0d573e6af1ed.html

Sharon Lerner. “The Trump Administration is waiving the public’s right to
affordable coronavirus treatments.” The Intercept. July 1, 2020.
https://theintercept.com/2020/07/01/coronavirus-treatment-drug-contracts-trump/

Ed Silverman and Nicholas Florko. “Some U.S. government contracts for
Covid-19 research could skirt affordable pricing laws.” STAT. July 1, 2020.
https://www.statnews.com/pharmalot/2020/07/01/covid19-coronavirus-vaccines-drug-prices/

Jonathon Gardner. "Federal coronavirus contracts dodge pricing oversight,
advocacy group says." BioPharma Dive. July 1, 2020.
https://www.biopharmadive.com/news/coronavirus-contracts-dodge-pricing-oversight/580896/

KEI's press advisory available here:
https://www.keionline.org/covid19-ota-contracts

--
Claire Cassedy
Knowledge Ecology International
1621 Connecticut Avenue NW
Suite 500
Washington, DC 20009
Tel.: 1.202.332.2670


More information about the Ip-health mailing list